Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel drug-coated balloon vs conventional balloon PTA for AV fistula restenosis
ChiCTR2500102680Phase 4Completed
- Sponsor
- Suqian People's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of paclitaxel in arteriovenous fistula stenosis and dialysis access dysfunction (VAF) (2 arms), sponsored by Suqian People's Hospital. Primary endpoints: minimum lumen diameter at 12 months, late lumen loss at 12 months and 3 more. Started May 2025; status: completed.
02
Drugs
paclitaxel
03
Conditions
arteriovenous fistula stenosisdialysis access dysfunction (VAF)
Beyond the preview
Go deeper on ChiCTR2500102680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102680.